Expression of NLK and its potential effect in ovarian cancer chemotherapy.
about
Nemo-like kinase is critical for p53 stabilization and function in response to DNA damageDownregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancerNLK functions to maintain proliferation and stemness of NSCLC and is a target of metforminLentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis.The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.Lentivirus‑delivered nemo‑like kinase small interfering RNA inhibits laryngeal cancer cell proliferation in vitro.Upregulated expression of polycomb protein Ring1 contributes to poor prognosis and accelerated proliferation in human hepatocellular carcinoma.Prognostic significance of Nemo-like kinase expression in patients with hepatocellular carcinoma.MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK.Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.Nemo-like kinase promotes etoposide-induced apoptosis of male germ cell-derived GC-1 cells in vitro.Polycomb group oncogene RING1 is over-expressed in non-small cell lung cancer.
P2860
Q34153536-1629594B-9476-4006-9769-A4CEF26332AFQ35755274-AA10FBCF-C15F-4E37-AA73-F357F6B345DBQ35976845-14CC6061-77FF-4202-9440-5E308F9E4504Q36206338-E403A5E4-3B69-4F51-922D-CBDDEDF14913Q37426884-3E834FB8-9665-4A14-B91B-D91B61429198Q38596991-7ACA93E0-E9D0-43D9-91C8-D337F219356CQ38845580-703AABF5-CB09-4342-8EDA-A89FE5A9A888Q38856913-94B1AE61-A62F-4258-BC35-B1053F3A6C92Q38869839-B5B7A4FE-7B7E-4FDA-950A-B41E1AA57079Q38891975-5E772919-A0BD-4A45-80AD-E355A2AA58A9Q39117288-AEE97E89-381C-4B14-96F5-6B6009551277Q39335932-F4BF6526-4ED7-4D2C-845F-FBA6E0325379Q53073353-48B5F404-F47D-430F-8C87-59020C781C38
P2860
Expression of NLK and its potential effect in ovarian cancer chemotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Expression of NLK and its potential effect in ovarian cancer chemotherapy.
@en
Expression of NLK and its potential effect in ovarian cancer chemotherapy.
@nl
type
label
Expression of NLK and its potential effect in ovarian cancer chemotherapy.
@en
Expression of NLK and its potential effect in ovarian cancer chemotherapy.
@nl
prefLabel
Expression of NLK and its potential effect in ovarian cancer chemotherapy.
@en
Expression of NLK and its potential effect in ovarian cancer chemotherapy.
@nl
P2093
P1476
Expression of NLK and its potential effect in ovarian cancer chemotherapy.
@en
P2093
Aiguo Shen
Chun Cheng
Shuyun Yang
Yeqing Huang
P304
P356
10.1097/IGC.0B013E3182262030
P577
2011-11-01T00:00:00Z